Your browser doesn't support javascript.
loading
A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.
Ahn, Youngkeun; Kim, Yongcheol; Chang, Kiyuk; Kim, Weon; Rhee, Moo-Yong; Cha, Kwang Soo; Hyon, Min Su; Shim, Chi Young; Lee, Sung Yun; Kim, Doo Il; Kim, Sang Wook; Lim, Sang-Wook; Han, Kyoo-Rok; Jo, Sang-Ho; Lee, Nae-Hee; Kwan, Jun; Ahn, Taehoon.
Affiliation
  • Ahn Y; Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju The Catholic University of Korea, Seoul St. Mary's Hospital Kyung Hee University Hospital, Seoul Dongguk University Ilsan Hospital, Goyang Pusan National University Hospital, Busan Soonchunhyang University Seoul Hospital, Seoul Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul Inje University Ilsan Paik Hospital, Goyang Inje University Haeundae Paik Hostpital, Busan Chung-Ang Univer
Medicine (Baltimore) ; 97(37): e12329, 2018 Sep.
Article in En | MEDLINE | ID: mdl-30212981

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Valsartan / Amlodipine, Valsartan Drug Combination / Essential Hypertension / Hydrochlorothiazide / Antihypertensive Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2018 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Valsartan / Amlodipine, Valsartan Drug Combination / Essential Hypertension / Hydrochlorothiazide / Antihypertensive Agents Type of study: Clinical_trials Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Medicine (Baltimore) Year: 2018 Document type: Article Country of publication: